Could an Available Drug Stop Dupuytren's in Its Tracks?

(MedPage Today) -- A drug already on the market for 20 years effectively reduced nodules associated with Dupuytren's disease in a mid-stage trial, researchers said. Patients receiving intranodular injections of adalimumab (Humira) showed significant...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news